Vancomycin flush as antibiotic prophylaxis for early catheter-related infections: A cost-effectiveness analysis

Supportive Care in Cancer

Volumn 17, Issue 3, 2009, Pages 285-293

  Penel, Nicolas ^a,b   Yazdanpanah, Yazdan ^b,c  

^a CENTRE OSCAR LAMBRET   (France)

^b UNIV LILLE   (France)

^c Service Universitaire des Maladies Infectieuses et du Voyageur   (France)

Author keywords

Catheter related infections; Cost effectiveness analysis; Decision analysis model; Risk adjusted prevention; Sensitivity analysis

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANCER PATIENT; CATHETER INFECTION; CATHETERIZATION; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DECISION MAKING; DECISION SUPPORT SYSTEM; DRUG HYPERSENSITIVITY; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION COMPLICATION; INFECTION PREVENTION; INFECTION RISK; MONTE CARLO METHOD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY ANALYSIS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 59449109852     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-008-0481-6     Document Type: Article

References (37)

1. PM Arnow EM Quinosing M Beach 1993 Consequence of intravascular catheter-related sepsis Clin Infect Dis 16 778 784
2. R Biffi F De Braud F Orsi 1998 Totally implantable central venous access ports for long-term chemotherapy Ann Oncol 9 767 773 doi:10.1023/A:1008392423469
3. WC Black 1990 The CE plane: a graphic representation of cost-effectiveness Med Decis Mak 10 212 214 doi:10.1177/0272989X9001000308
4. C Carbon 1999 Cost of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci J Antimicrob Chemother 44S A31 A36 doi:10.1093/jac/44.suppl-1.31
5. J Carrattala J Niubo A Fernandez-Sevilla 1999 Randomized double blind trial of antibiotic-lock technique for prevention of Gram-positive central venous catheter-related infection in neutropenic patients with cancer Antimicrob Agents Chemother 43 220 224
6. CJ Crnich DG Maki 2002 The promise of novel technology for the prevention of intravascular device-related bloodstream infections. I. Pathogens and short-term devices Clin Infect Dis 34 1232 1242 doi:10.1086/339863
7. B Di Givone C Chenoweth C Watts 2000 The attributable mortality and costs of primary nosocomial bloodstream infection in the intensive care unit Am J Respir Crit Care Med 160 976 981
8. JB Dimick RK Pelz R Consurji 2001 Increased resource use associated with catheter-related bloodstream infections in the surgical intensive care unit Arch Surg 136 229 234 doi:10.1001/archsurg.136.2.229
9. JC Garrelts WD Horst B Silkey S Gagnon 1994 A pharmacoeconomic model to evaluate antibiotic costs Pharmacotherapy 14 438 445
10. WT Huang TY Chan WC Su CJ Yen CJ Tsao 2004 Implantable venous port-related infections in cancer patients Support Care Cancer 12 197 201 doi:10.1007/s00520-003-0576-z
11. S Kachroo T Dao F Zabaneh 2006 Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant Enterococcus colonization Ann Pharmacother 40 331 335 doi:10.1345/aph.1G565
12. D Kluger D Maki 2000 The relative risk of intravascular device-related bloodstream infection with different types of intravascular devices in adults: a meta-analysis of 2006 published studies Infect Control Hosp Epidemiol 21 95 96
13. SH Lim MP Smith SJ Machin AH Goldstone 1990 Prophylactic teicoplanin during the insertion of Hickman catheters Br J Haematol 76 Suppl 2 27 29 doi:10.1111/j.1365-2141.1990.tb07932.x
14. D Magid B Shwartz J Craft 1992 Prevention of Lyme disease after tick bite. A cost-effectiveness analysis N Engl J Med 327 324 341
15. DB Mark MA Hlatky RM Califf 1995 Cost-effectiveness analysis of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for actuates myocardial infarction N Engl J Med 332 1418 1424 doi:10.1056/NEJM199505253322106
16. MJ Matar J Tarrand I Raad KVI Rolston 2006 Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer Am J Infect Control 34 534 536 doi:10.1016/j.ajic.2006.04.205
17. LA Mermel BM Farr RJ Sheretz 2001 Guidelines for the management of intravascular catheter-related infections Clin Infect Dis 32 1249 1272 doi:10.1086/320001
18. NP O'Grady M Alexander EP Dellinger 2002 Guidelines for the prevention of the intravascular catheter related infections Pediatrics 110 51 75 doi:10.1542/peds.110.5.e51
19. RK Pelcz PA Lipsett SM Swoboda 2002 Vancomycin sensitive and vancomycin-resistant enterococcal infection in the ICU: attributable costs and outcomes Intensive Care Med 28 692 697 doi:10.1007/s00134-002-1276-8
20. N Penel C Fournier D Lefebvre JL Lefebvre 2005 Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa: study of 260 surgical procedures Oral Oncol 41 294 303 doi:10.1016/j.oraloncology.2004.08.011
21. N Penel Y Yazdanpanah MP Chauvet 2007 Prevention of surgical site infection after breast cancer surgery by targeted prophylactic antibiotic in patient at high risk of surgical site infection J Surg Oncol 96 124 129 doi:10.1002/jso.20796
22. N Penel JC Neu S Clisant 2007 Risk factors for early catheter-related infections in cancer patients Cancer 110 1586 1592 doi:10.1002/cncr.22942
23. D Pittet D Tarara RP Wenzel 1994 Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs and attributable mortality JAMA 271 1598 1601 doi:10.1001/jama.271.20.1598
24. Public Health Focus 1992 Surveillance, prevention and control of nosocomial infection Morb Mortal Wkly Rep 41 783 787
25. B Renaud C Brun-Buison 2001 Outcomes of primary and catheter-related bacteremia: a cohort and case-control study in critically ill patients Am J Respir Crit Care Med 163 1584 1590
26. J Rello A Ochagava E Sabanes 2000 Evaluation of outcomes of intravenous catheter-related infections in critically ill patients Am J Respir Crit Care Med 162 1027 1030
27. VD Rosenthal DG Maki 2004 Prospective study of the impact of open and closed infusion rates of central venous catheter-associated bacteremia Am J Infect Control 32 135 141 doi:10.1016/j.ajic.2003.12.002
28. A Safdar KVI Rolston 2006 Vancomycin, tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer Cancer 106 1815 1820 doi:10.1002/cncr.21801
29. V Sakka S Tsiodras L Galani 2008 Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci Clin Microbiol Infect 14 14 21 doi:10.1111/j.1469-0691.2007.01840.x
30. G Sakoulas PA Moise-Broder J Schentag 2004 Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia J Clin Microbiol 42 2398 2402 doi:10.1128/JCM.42.6.2398-2402.2004
31. JE Siegel MC Weinstein LB Russel 1996 Recommendations for reporting cost-effectiveness analyses JAMA 276 1339 1341 doi:10.1001/jama.276.16.1339
32. AD Slonim HC Kurtimes BM Sprague 2001 The costs associated with nosocomial bloodstream infections in the pediatric intensive care unit Pediatr Crit Care Med 2 170 174 doi:10.1097/00130478-200104000-00012
33. AF Shor CW Humphreys DL Helman 2003 New choices for central venous catheters: potential financial implications Chest 124 275 284 doi:10.1378/chest.124.1.275
34. X Song A Srinivasan D Plant TM Perl 2003 Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay and costs Infect Control Hosp Epidemiol 24 238 241 doi:10.1086/502196
35. G Todeschini C Tecchio C Borghero 2006 Association between Enterococcus bacteriemi and death in neutropenic patients with haematological malignancies J Infect 53 266 273 doi:10.1016/j.jinf.2005.11.012
36. MD Van de Wetering JM Van Woensel 2007 Prophylactic antibiotics for preventing early central venous catheter Gram positive infection in oncology patients Cochrane Database Syst Rev 2 CD003295 Review
37. AK Zaas X Song P Tucker TM Perl 2002 Risk factors for the development of vancomycin-resistant enterococcal bloodstream infections in patients with cancer who are colonized with vancomycin-resistant enterococci Clin Infect Dis 35 1139 1146 doi:10.1086/342904